Issued Patents All Time
Showing 1–25 of 25 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12427146 | C-terminal SRC kinase inhibitors | Xing Dai, Yueheng Jiang, Yanqin LIU, Zhe SHI, Zhenwu Wang +2 more | 2025-09-30 |
| 12391677 | Thyroid hormone receptor agonists | Xing Dai, Yueheng Jiang, Yanqin LIU, Zixing HAN, Zhenwu Wang +2 more | 2025-08-19 |
| 12187736 | Selective estrogen receptor degraders and uses thereof | Xing Dai | 2025-01-07 |
| 12173010 | Heterocyclic compounds, preparation methods therefor, and methods of uses thereof | Xing Dai, Yueheng Jiang, Yanqin LIU, Haotao NIU, Zhenwu Wang +4 more | 2024-12-24 |
| 12110289 | Heterocyclic compounds, preparation methods and uses thereof | Xing Dai, Yueheng Jiang, Yanqin LIU, Zhe SHI, Zhenwu Wang +4 more | 2024-10-08 |
| 12094384 | Display panel and display device with reduced charge accumulation in semiconductor layer | Zhiyong Xiong, Rui Ding | 2024-09-17 |
| 11969425 | Inhibitor of indoleamine-2,3-dioxygenase (IDO) | Xing Dai | 2024-04-30 |
| 11900876 | Display panel, method for driving the same, and display apparatus | — | 2024-02-13 |
| 11847960 | Display panel, method for driving the same, and display apparatus | Zhiyong Xiong | 2023-12-19 |
| 11699373 | Display panel and display device with reduced charge accumulation in semiconductor layer | Zhiyong Xiong, Rui Ding | 2023-07-11 |
| 11691981 | Heterocyclic compounds, preparation methods therefor, and methods of uses thereof | Xing Dai, Yueheng Jiang, Yanqin LIU, Haotao NIU, Zhenwu Wang +4 more | 2023-07-04 |
| 11374084 | Organic light emitting display panel and display device | — | 2022-06-28 |
| 11014936 | Selective estrogen receptor degraders and uses thereof | Xing Dai | 2021-05-25 |
| 10980807 | Inhibitor of indoleamine-2,3-dioxygenase (IDO) | Xing Dai | 2021-04-20 |
| 10913797 | Anti-PD-1 antibodies and therapeutic uses thereof | Jieyi Wang, Liqun Dong | 2021-02-09 |
| 10647724 | Selective estrogen receptor degraders and uses thereof | Xing Dai | 2020-05-12 |
| 9540377 | 2,6,7,8 substituted purines as HDM2 inhibitors | Carolyn Michele Cammarano, Matthew Christopher, Christopher J. Dinsmore, Ronald J. Doll, Francesc Xavier Fradera Llinas +16 more | 2017-01-10 |
| 9062071 | Substituted piperidines as HDM2 inhibitors | Yao-Dong Ma, Manami Shizuka, Timothy J. Guzi, Yuan Liu, Yuan Tian +10 more | 2015-06-23 |
| 8859776 | Substituted piperidines that increase p53 activity and the uses thereof | Stephane L. Bogen, Yao-Dong Ma, Brian Robert Lahue, Latha G. Nair, Manami Shizuka +15 more | 2014-10-14 |
| 8034907 | Polynucleotides encoding soluble, stable forms of human double minute 2 polypeptides | Shahriar Shane Taremi, Gaolian Xie, Thomas Hesson, Jose S. Duca, Corey Strickland +4 more | 2011-10-11 |
| 7888474 | HDM2 polypeptides | Thomas Hesson, Hung V. Le, Yao-Dong Ma, Vincent S. Madison, Anthony F. Mannarino +6 more | 2011-02-15 |
| 7884107 | Substituted piperidines that increase P53 activity and the uses thereof | Yao-Dong Ma, Brian Robert Lahue, Gerald W. Shipps, Jr., Stephane L. Bogen, Matthew E. Voss +10 more | 2011-02-08 |
| 7811562 | Biomarkers for pre-selection of patients for anti-IGF1R therapy | Yan Wang, Jonathan A. Pachter, Ming-Cheng Liu | 2010-10-12 |
| 7705127 | HDM2 Polypeptides | Thomas Hesson, Hung V. Le, Yao-Dong Ma, Vincent S. Madison, Anthony F. Mannarino +6 more | 2010-04-27 |
| 7632920 | Soluble, stable form of HDM2, crystalline forms thereof and methods of use thereof | Shahriar Shane Taremi, Gaolian Xie, Thomas Hesson, Jose S. Duca, Corey Strickland +4 more | 2009-12-15 |